1. |
杨文英. 中国糖尿病的流行特点及变化趋势[J]. 中国科学(生命科学), 2018, 48(8): 812-819. DOI: 10.1360/N052018-00005.Yang WY. Epidemiology and trends in diabetes in China[J]. Science in China (Series C), 2018, 48(8): 812-819. DOI: 10.1360/N052018-00005.
|
2. |
Weng JP, Bi Y. Epidemiological status of chronic diabetic complications in China[J]. Chin Med J (Engl), 2015, 128(24): 3267-3269. DOI: 10.4103/0366-6999.171350.
|
3. |
中华医学会糖尿病学分会糖尿病慢性并发症调查组. 全国住院糖尿病患者慢性并发症及其相关危险因素10年回顾性调查分析[J]. 中国糖尿病杂志, 2003, 11(4): 232-237. DOI: 10.3321/j.issn:1006-6187.2003.04.002.Investigation Group of Chronic Complications of Diabetes, Chinese Diabetes Society of Chinese Medical Association. Chronic diabetic complications and related macro-vascular diseases of in-patients with diabetes in mainland of China: a national retrospective analysis in recent 10 years[J]. Chin J Diabetes, 2003, 11(4): 232-237. DOI: 10.3321/j.issn:1006-6187.2003.04.002.
|
4. |
Spaide RF, Fujimoto JG, Waheed NK, et al. Optical coherence tomography angiography[J]. Prog Retin Eye Res, 2018, 64: 1-55. DOI: 10.1016/j.preteyeres.2017.11.003.
|
5. |
Um T, Seo EJ, Kim YJ, et al. Optical coherence tomography angiography findings of type 1 diabetic patients with diabetic retinopathy, in comparison with type 2 patients[J]. Graefe's Arch Clin Exp Ophthalmol, 2020, 258(2): 281-288. DOI: 10.1007/s00417-019-04517-6.
|
6. |
American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2020[J]. Diabetes Care, 2020, 43(Suppl 1): S135-151. DOI: 10.2337/dc20-S011.
|
7. |
中华医学会眼科学会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014年)[J]. 中华眼科杂志, 2014, 50(11): 851-865. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.014.Ocular Fundus Diseases Group of Ophthalmological Society of Chinese Medical Association. Guidelines for clinical diagnosis and treatment of diabetic retinopathy in China(2014)[J]. Chin J Ophthalmol, 2014, 50(11): 851-865. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.014.
|
8. |
Campbell JP, Zhang M, Hwang TS, et al. Detailed cascular anatomy of the human retina by projection-resolved optical coherence tomography angiography[J/OL]. Sci Rep, 2017, 7: 42201[2017-02-10]. https://pubmed.ncbi.nlm.nih.gov/28186181/. DOI: 10.1038/srep42201.
|
9. |
李琳, 李全民. 糖尿病肾病美国糖尿病协会指南更新要点及治疗进展[J]. 中华糖尿病杂志, 2020, 12(6): 424-428. DOI: 10.3760/cma.j.cn115791-20200320-00166.Li L, Li QM. Update and progress of American Diabetes Association guidelines for diabetic kidney disease[J]. Chin J of Diabetes Mellitus, 2020, 12(6): 424-428. DOI: 10.3760/cma.j.cn115791-20200320-00166.
|
10. |
El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, et al. Retinopathy as a predictor of other diabetic complications[J]. Int Ophthalmol, 2001, 24(1): 1-11. DOI: 10.1023/a:1014409829614.
|
11. |
Hsing SC, Lee CC, Lin C, et al. The severity of diabetic retinopathy is an independent factor for the progression of diabetic nephropathy[J]. J Clin Med, 2020, 10(1): 3. DOI: 10.3390/jcm10010003.
|
12. |
Martín-Merino E, Fortuny J, Rivero-Ferrer E, et al. Incidence of retinal complications in a cohort of newly diagnosed diabetic patients[J/OL]. PLoS One, 2014, 9(6): e100283[2014-06-25]. https://pubmed.ncbi.nlm.nih.gov/24963628/. DOI: 10.1371/journal.pone.0100283.
|
13. |
Cankurtaran V, Inanc M, Tekin K, et al. Retinal microcirculation in predicting diabetic nephropathy in type 2 diabetic patients without retinopathy[J]. Ophthalmologica, 2020, 243(4): 271-279. DOI: 10.1159/000504943.
|
14. |
Lou J, Jing L, Yang H, et al. Risk factors for diabetic nephropathy complications in community patients with type 2 diabetes mellitus in Shanghai: logistic regression and classification tree model analysis[J]. Int J Health Plann Manage, 2019, 34(3): 1013-1024. DOI: 10.1002/hpm.2871.
|
15. |
Blair NP, Wanek J, Felder AE, et al. Retinal oximetry and vessel diameter measurements with a commercially available scanning laser ophthalmoscope in diabetic retinopathy[J]. Invest Ophthalmol Vis Sci, 2017, 58(12): 5556-5563. DOI: 10.1167/iovs.17-21934.
|
16. |
Fondi K, Wozniak PA, Howorka K, et al. Retinal oxygen extraction in individuals with type 1 diabetes with no or mild diabetic retinopathy[J]. Diabetologia, 2017, 60(8): 1534-1540. DOI: 10.1007/s00125-017-4309-0.
|
17. |
滕娟, 余海跃, 陈志萍, 等. 2型糖尿病患者尿微量白蛋白含量与黄斑区视网膜微循环相关性分析[J]. 眼科新进展, 2020, 40(10): 952-956. DOI: 10.13389/j.cnki.rao.2020.0214.Teng J, Yu HY, Chen ZP, et al. Correlation analysis between microalbumin changes and macular retinal microcirculation in type 2 diabetic patients[J]. Rec Adv in Ophthalmol, 2020, 40(10): 952-956. DOI: 10.13389/j.cnki.rao.2020.0214.
|
18. |
Sasso FC, Pafundi PC, Gelso A, et al. Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: findings from no blind study[J]. Nutr Metab Cardiovasc Dis, 2019, 29(9): 923-930. DOI: 10.1016/j.numecd.2019.05.065.
|
19. |
Kaewput W, Thongprayoon C, Rangsin R, et al. Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: a multicenter nationwide cross-sectional study[J]. World J Nephrol, 2019, 8(2): 33-43. DOI: 10.5527/wjn.v8.i2.33.
|
20. |
Jiang S, Yu T, Zhang Z, et al. Diagnostic performance of retinopathy in the detection of diabetic nephropathy in type 2 diabetes: a systematic review and meta-analysis of 45 studies[J]. Ophthalmic Res, 2019, 62(2): 68-79. DOI: 10.1159/000500833.
|
21. |
曾运考, 杨大卫, 曹丹, 等. 早期不同分期糖尿病视网膜病变黄斑区血流密度及血管结构改变[J]. 中华实验眼科杂志, 2020, 38(9): 783-787. DOI: 10.3760/cma.j.cn115989-20200715-00497.Zeng YK, Yang DW, Cao D, et al. Changes of macular vessel density and structures in different early stages of diabetic retinopathy[J]. Chin J Exp Ophthalmol, 2020, 38(9): 783-787. DOI: 10.3760/cma.j.cn115989-20200715-00497.
|
22. |
Khatri A, Pradhan E, Kc BK, et al. Detection, localization, and characterization of vision-threatening features of microaneurysms using optical coherence tomography angiography in diabetic maculopathy[J]. Eur J Ophthalmol, 2021, 31(3): 1208-1215. DOI: 10.1177/1120672120924609.
|
23. |
DaCosta J, Bhatia D, Talks J. The use of optical coherence tomography angiography and optical coherence tomography to predict visual acuity in diabetic retinopathy[J]. Eye (Lond), 2020, 34(5): 942-947. DOI: 10.1038/s41433-019-0606-9.
|
24. |
中华医学会糖尿病学分会微血管并发症学组. 中国糖尿病肾脏疾病防治临床指南[J]. 中华糖尿病杂志, 2019, 11(1): 15-28. DOI: 10.3760/cma.j.issn.1674-5809.2019.01.004.Microvascular Complications Group, Diabetes Society, Chinese Medical Association. Chinese clinical practice guideline of diabetic kidney disease[J]. Chin J of Diabetes Mellitus, 2019, 11(1): 15-28. DOI: 10.3760/cma.j.issn.1674-5809.2019.01.004.
|
25. |
Ashimatey BS, Green KM, Chu Z, et al. Impaired retinal vascular reactivity in diabetic retinopathy as assessed by optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2019, 60(7): 2468-2473. DOI: 10.1167/iovs.18-26417.
|
26. |
Lee H, Lee M, Chung H, et al. Quantification of retinal vessel tortuosity in diabetic retinopathy using optical coherence tomography angiography[J]. Retina, 2018, 38(5): 976-985. DOI: 10.1097/iae.0000000000001618.
|
27. |
Sousa DC, Leal I, Moreira S, et al. A protocol to evaluate retinal vascular response using optical coherence tomography angiography[J]. Front Neurosci, 2019, 13: 566. DOI: 10.3389/fnins.2019.00566.
|